DK0795547T3 - (Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradyk - Google Patents
(Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradykInfo
- Publication number
- DK0795547T3 DK0795547T3 DK97103163T DK97103163T DK0795547T3 DK 0795547 T3 DK0795547 T3 DK 0795547T3 DK 97103163 T DK97103163 T DK 97103163T DK 97103163 T DK97103163 T DK 97103163T DK 0795547 T3 DK0795547 T3 DK 0795547T3
- Authority
- DK
- Denmark
- Prior art keywords
- bradyk
- benzyloxyquinolines
- acylaminoalkyl
- aminoalkyl
- oxy
- Prior art date
Links
- NWIAYUZWWLSLBI-UHFFFAOYSA-N 2-phenylmethoxyquinoline Chemical class C=1C=C2C=CC=CC2=NC=1OCC1=CC=CC=C1 NWIAYUZWWLSLBI-UHFFFAOYSA-N 0.000 title 1
- 125000004103 aminoalkyl group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19609827A DE19609827A1 (de) | 1996-03-13 | 1996-03-13 | Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0795547T3 true DK0795547T3 (da) | 2000-09-18 |
Family
ID=7788139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97103163T DK0795547T3 (da) | 1996-03-13 | 1997-02-27 | (Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradyk |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6140341A (da) |
| EP (1) | EP0795547B1 (da) |
| JP (1) | JP4317597B2 (da) |
| KR (1) | KR970065521A (da) |
| AR (1) | AR006189A1 (da) |
| AT (1) | ATE192738T1 (da) |
| AU (1) | AU1621797A (da) |
| BR (1) | BR9701267A (da) |
| CA (1) | CA2199771A1 (da) |
| CZ (1) | CZ76697A3 (da) |
| DE (2) | DE19609827A1 (da) |
| DK (1) | DK0795547T3 (da) |
| ES (1) | ES2148858T3 (da) |
| GR (1) | GR3033415T3 (da) |
| HR (1) | HRP970138A2 (da) |
| HU (1) | HUP9700566A1 (da) |
| ID (1) | ID16217A (da) |
| IL (1) | IL120427A0 (da) |
| NO (1) | NO971136L (da) |
| PL (1) | PL318923A1 (da) |
| PT (1) | PT795547E (da) |
| SI (1) | SI0795547T1 (da) |
| SK (1) | SK32097A3 (da) |
| TR (1) | TR199700184A2 (da) |
| TW (1) | TW363891B (da) |
| ZA (1) | ZA972129B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6376670B1 (en) | 1997-06-19 | 2002-04-23 | Sepracor Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| US6172084B1 (en) | 1997-06-19 | 2001-01-09 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| US6207679B1 (en) | 1997-06-19 | 2001-03-27 | Sepracor, Inc. | Antimicrobial agents uses and compositions related thereto |
| US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| EP1914236A1 (en) | 2002-04-10 | 2008-04-23 | Ortho-McNeil Pharmaceutical, Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| ITMI20021247A1 (it) * | 2002-06-07 | 2003-12-09 | Menarini Ricerche Spa | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| MY156662A (en) * | 2007-11-01 | 2016-03-15 | Acucela Inc | Amine derivative compounds for treating ophthalmic diseases and disorders |
| AR113839A1 (es) | 2017-11-24 | 2020-06-17 | Pharvaris B V | Antagonistas del receptor b2 de bradiquinina |
| AR118983A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| UY38706A (es) | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| MA61123B1 (fr) | 2021-08-05 | 2024-06-28 | Pharvaris Gmbh | Composition à base de lipides pour l'administration par voie orale d'antagonistes des récepteurs b2 de la bradykinine |
| ES3062067T3 (en) | 2022-03-25 | 2026-04-08 | Pharvaris Gmbh | Solid composition comprising solubilised bradykinin b2-receptor antagonists |
| US20250268887A1 (en) | 2022-03-25 | 2025-08-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5216165A (en) * | 1990-10-03 | 1993-06-01 | American Home Products Corporation | N-substituted aminoquinolines as analgesic agents |
| US5288725A (en) * | 1992-10-15 | 1994-02-22 | Merck & Co., Inc. | Pyrroloquinoline Bradykinin antagonist |
| AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| US6756388B1 (en) * | 1993-10-12 | 2004-06-29 | Pfizer Inc. | Benzothiophenes and related compounds as estrogen agonists |
| ES2218554T3 (es) * | 1994-10-27 | 2004-11-16 | Fujisawa Pharmaceutical Co., Ltd. | Piridopirimidonas, quinolinas y n-heterociclos condensados que son antagonistas de bradiquinina. |
| FR2735128B1 (fr) * | 1995-06-07 | 1997-07-25 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique. |
| FR2737892B1 (fr) * | 1995-08-17 | 1997-10-24 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique |
-
1996
- 1996-03-13 DE DE19609827A patent/DE19609827A1/de not_active Withdrawn
-
1997
- 1997-02-27 DE DE59701617T patent/DE59701617D1/de not_active Expired - Lifetime
- 1997-02-27 ES ES97103163T patent/ES2148858T3/es not_active Expired - Lifetime
- 1997-02-27 PT PT97103163T patent/PT795547E/pt unknown
- 1997-02-27 AT AT97103163T patent/ATE192738T1/de not_active IP Right Cessation
- 1997-02-27 DK DK97103163T patent/DK0795547T3/da active
- 1997-02-27 SI SI9730063T patent/SI0795547T1/xx unknown
- 1997-02-27 EP EP97103163A patent/EP0795547B1/de not_active Expired - Lifetime
- 1997-03-10 ID IDP970758A patent/ID16217A/id unknown
- 1997-03-11 SK SK320-97A patent/SK32097A3/sk unknown
- 1997-03-11 AU AU16217/97A patent/AU1621797A/en not_active Abandoned
- 1997-03-11 TW TW086102960A patent/TW363891B/zh active
- 1997-03-11 AR ARP970100968A patent/AR006189A1/es unknown
- 1997-03-11 HU HU9700566A patent/HUP9700566A1/hu unknown
- 1997-03-11 TR TR97/00184A patent/TR199700184A2/xx unknown
- 1997-03-12 NO NO971136A patent/NO971136L/no unknown
- 1997-03-12 HR HR19609827.0A patent/HRP970138A2/xx not_active Application Discontinuation
- 1997-03-12 CZ CZ97766A patent/CZ76697A3/cs unknown
- 1997-03-12 KR KR1019970008175A patent/KR970065521A/ko not_active Withdrawn
- 1997-03-12 PL PL97318923A patent/PL318923A1/xx unknown
- 1997-03-12 CA CA002199771A patent/CA2199771A1/en not_active Abandoned
- 1997-03-12 BR BR9701267A patent/BR9701267A/pt unknown
- 1997-03-12 IL IL12042797A patent/IL120427A0/xx unknown
- 1997-03-12 US US08/820,321 patent/US6140341A/en not_active Expired - Fee Related
- 1997-03-12 ZA ZA9702129A patent/ZA972129B/xx unknown
- 1997-03-12 JP JP05783497A patent/JP4317597B2/ja not_active Expired - Fee Related
-
2000
- 2000-05-16 GR GR20000401105T patent/GR3033415T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1621797A (en) | 1997-09-18 |
| DE59701617D1 (de) | 2000-06-15 |
| ZA972129B (en) | 1997-09-15 |
| EP0795547A1 (de) | 1997-09-17 |
| ATE192738T1 (de) | 2000-05-15 |
| TW363891B (en) | 1999-07-11 |
| CZ76697A3 (en) | 1997-10-15 |
| JP4317597B2 (ja) | 2009-08-19 |
| KR970065521A (ko) | 1997-10-13 |
| TR199700184A2 (xx) | 1997-10-21 |
| PL318923A1 (en) | 1997-09-15 |
| HRP970138A2 (en) | 1998-04-30 |
| MX9701857A (es) | 1997-09-30 |
| HU9700566D0 (en) | 1997-04-28 |
| DE19609827A1 (de) | 1997-09-18 |
| ID16217A (id) | 1997-09-11 |
| PT795547E (pt) | 2000-10-31 |
| EP0795547B1 (de) | 2000-05-10 |
| GR3033415T3 (en) | 2000-09-29 |
| SI0795547T1 (en) | 2000-10-31 |
| BR9701267A (pt) | 1999-01-12 |
| AR006189A1 (es) | 1999-08-11 |
| JPH101472A (ja) | 1998-01-06 |
| US6140341A (en) | 2000-10-31 |
| HUP9700566A1 (hu) | 2000-08-28 |
| CA2199771A1 (en) | 1997-09-13 |
| NO971136L (no) | 1997-09-15 |
| IL120427A0 (en) | 1997-07-13 |
| NO971136D0 (no) | 1997-03-12 |
| SK32097A3 (en) | 1998-01-14 |
| ES2148858T3 (es) | 2000-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993003D0 (no) | Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter | |
| NO20012158D0 (no) | Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav | |
| NO991815D0 (no) | Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter | |
| DK0740668T3 (da) | Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse | |
| DK0676409T3 (da) | Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| DK1202733T3 (da) | 3(5)-amino-pyrazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler | |
| NO20012058D0 (no) | 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler | |
| DK1180518T3 (da) | 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK641589A (da) | N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer | |
| DK0885234T3 (da) | Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| NO984080L (no) | Nye arylglycinamid-derivater, fremgangsmÕte for fremstilling derav og blandinger som inneholder disse forbindelser | |
| NO20005146L (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
| NO975977D0 (no) | Substituerte purinderivater, fremgangsmåter for fremstilling og anvendelse derav | |
| DK0795547T3 (da) | (Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradyk | |
| DK0770059T3 (da) | Substituerede benzamidiner, deres fremstilling og deres anvendelse som lægemidler | |
| DK1261697T3 (da) | Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf | |
| NO20022834L (no) | Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne | |
| DK0915845T3 (da) | Acryloylsubstituerede distamycinderivater, fremgangsmåde til fremstilling deraf og anvendelse som antitumormidler og antivirale midler | |
| NO985307L (no) | Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende | |
| NO974934D0 (no) | 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmåte for deres fremstilling og legemidler som inneholder disse forbindelsene | |
| NO960272L (no) | Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme | |
| DK0727416T3 (da) | Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som | |
| NO20010219L (no) | Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel | |
| NO20001288D0 (no) | Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel | |
| NO984444L (no) | Benzothiofener, formuleringer som inneholder de samme og fremgangsmÕter |